Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
10.16
-0.16 (-1.55%)
May 12, 2026, 3:00 PM CST
SHA:603229 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,150 | 1,223 | 1,096 | 1,124 | 608.85 | 564.55 |
Trading Asset Securities | 3.87 | 3.94 | 2.24 | - | 4.02 | 110 |
Cash & Short-Term Investments | 1,154 | 1,227 | 1,099 | 1,124 | 612.87 | 674.55 |
Cash Growth | 3.95% | 11.65% | -2.29% | 83.44% | -9.14% | -8.73% |
Accounts Receivable | 321.31 | 146.41 | 196.58 | 132.75 | 134.81 | 66.24 |
Other Receivables | 1.96 | 1.79 | 1.63 | 2.82 | 8.49 | 1.49 |
Receivables | 323.26 | 148.2 | 198.21 | 135.57 | 143.3 | 67.73 |
Inventory | 367.83 | 398.3 | 400.95 | 365.18 | 320.57 | 243.44 |
Other Current Assets | 34.17 | 42.32 | 11.48 | 49.75 | 59.97 | 34.86 |
Total Current Assets | 1,879 | 1,815 | 1,709 | 1,675 | 1,137 | 1,021 |
Property, Plant & Equipment | 1,038 | 1,037 | 1,041 | 1,046 | 950.94 | 601.46 |
Long-Term Investments | 72.91 | 72.56 | 72.56 | 67.37 | 50.14 | 32.64 |
Other Intangible Assets | 150.56 | 151.56 | 155.39 | 150.37 | 161.98 | 164.2 |
Long-Term Deferred Tax Assets | 5.74 | 3.82 | 0.46 | - | 6.87 | 4.47 |
Other Long-Term Assets | 10.89 | 5.35 | 3.99 | 12.71 | 8.69 | 16.1 |
Total Assets | 3,157 | 3,085 | 2,982 | 2,952 | 2,315 | 1,839 |
Accounts Payable | 225.01 | 270.1 | 351.64 | 410.85 | 519.32 | 402.25 |
Accrued Expenses | 21.83 | 42.24 | 46.87 | 40.11 | 42.91 | 31.63 |
Short-Term Debt | 440.67 | 410.61 | 270.31 | 300.26 | 160.12 | 65.07 |
Current Portion of Long-Term Debt | 1.56 | 1.79 | - | - | 9.16 | - |
Current Portion of Leases | - | - | 1.04 | 0.87 | - | - |
Current Income Taxes Payable | 16.31 | 7.85 | 2.53 | 10.21 | - | 5.81 |
Current Unearned Revenue | 1.1 | 0.96 | 0.91 | 7.06 | 12.63 | 23.23 |
Other Current Liabilities | 4.6 | 2.47 | 1.23 | 1.61 | 1.28 | 2.33 |
Total Current Liabilities | 711.09 | 736.02 | 674.53 | 770.97 | 745.42 | 530.32 |
Long-Term Debt | 43.99 | 44.25 | - | - | 72.74 | 44.86 |
Long-Term Leases | - | - | 1.08 | 2.04 | - | - |
Long-Term Unearned Revenue | 34.57 | 35.62 | 34.89 | 34.91 | 23.51 | 9.46 |
Long-Term Deferred Tax Liabilities | - | - | - | 2.07 | 12.51 | - |
Total Liabilities | 789.65 | 815.89 | 710.5 | 809.99 | 854.19 | 584.64 |
Common Stock | 830.3 | 830.3 | 830.3 | 593.07 | 401.87 | 287.05 |
Additional Paid-In Capital | 440.23 | 440.23 | 440.23 | 677.45 | 394.72 | 509.54 |
Retained Earnings | 1,147 | 1,050 | 1,002 | 871.92 | 665.46 | 459.36 |
Treasury Stock | -50.01 | -50.01 | - | - | - | - |
Comprehensive Income & Other | -0.81 | -1.1 | -0.83 | -0.86 | -0.91 | -1.14 |
Shareholders' Equity | 2,367 | 2,269 | 2,272 | 2,142 | 1,461 | 1,255 |
Total Liabilities & Equity | 3,157 | 3,085 | 2,982 | 2,952 | 2,315 | 1,839 |
Total Debt | 486.22 | 456.65 | 272.43 | 303.17 | 242.02 | 109.93 |
Net Cash (Debt) | 667.38 | 769.86 | 826.1 | 821.06 | 370.85 | 564.62 |
Net Cash Growth | -18.39% | -6.81% | 0.61% | 121.40% | -34.32% | -19.12% |
Net Cash Per Share | 0.83 | 0.94 | 1.00 | 1.00 | 0.46 | 0.71 |
Filing Date Shares Outstanding | 805.52 | 779.87 | 828.3 | 830.3 | 787.66 | 787.66 |
Total Common Shares Outstanding | 805.52 | 779.87 | 830.3 | 830.3 | 787.66 | 787.66 |
Working Capital | 1,168 | 1,079 | 1,035 | 903.76 | 391.28 | 490.26 |
Book Value Per Share | 2.94 | 2.91 | 2.74 | 2.58 | 1.86 | 1.59 |
Tangible Book Value | 2,217 | 2,118 | 2,116 | 1,991 | 1,299 | 1,091 |
Tangible Book Value Per Share | 2.75 | 2.72 | 2.55 | 2.40 | 1.65 | 1.38 |
Buildings | - | - | 261.11 | 224.84 | 168.11 | 150.71 |
Machinery | - | - | 559.12 | 510.1 | 278.07 | 223.16 |
Construction In Progress | - | - | 495.66 | 526.23 | 685.01 | 379.24 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.